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Summary: Determination of 25-hydroxyvitamin D [25(OH)D]
represents a unique challenge, considering its lipophilic na -
ture. Considering the widespr ead prevalence of vitamin D
deficiency, which leads to incr easing number of r equests for
25(OH)D determination, immunoassay measur ements
adjusted to automated analyzers ar e being developed.
Because of the variability among assays, it is of ten difficult to
monitor vitamin D status and supplementation. The aim of
this study was to compar e the results of two immunoassays
with high performance liquid chromatography with ultraviolet
detection (HPLC-UV). Also, the aim was to estimate vitamin
D status, since up to date the pr evalence of vitamin D defi-
ciency in Serbia was not examined. W e have evaluated ana-
lytical characteristics of two automated immunoassays for
25(OH)D determination, from Roche (Cobas® e601) and
Abbott (Architect). For comparison studies we used HPLC
analysis of 25-(OH)- Vitamin D3/D2 from Chromsystems
(Waters isocratic system). In or der to estimate vitamin D sta-
tus in general population, we have sear ched the database of
the laboratory information system and analyzed the data from
533 patients whose 25(OH)D was deter mined together with
intact parathyroid hormone (iPTH). For imprecision assess-
ment, four ser um pools wer e prepared with following
25(OH)D concentrations: 35 nmol/L, ∼50 nmol/L, ∼75
nmol/L and ∼125 nmol/L. Obtai ned CVs for Roche method
were 1.5–2.8% for within-run and 4.0–6.7% for between-run
imprecision. For Abbott method, CVs wer e 0.7–4.4% for
Kratak sadr`aj: Odre|ivanje 25-hidroksivitamina D
[25(OH)D] predstavlja jedinstven izazov , s obzir om da je
visoko lipofilno jedinjenje. Visoka pr evalencija deficijencije
vitamina D uzrok je pove}anja broja zahteva za odre|ivanjem
25(OH)D, zbog ~ega se razvijaju imunohemijske metode pri-
lago|ene auto ma tizovanim sistemima. ^esto je te{ko pratiti
status vitamina D i suplementaciju zbog varijabilnosti izme|u
testova. Cilj ove studije bio je da se upor ede rezultati dve
imunohemijske metode sa te~nom hr omatografijom visoke
efikasnosti sa detekcijom u ultraljubi~astom delu spektra
(HPLC-UV). Ta ko|e, cilj je bio i procena statusa vitamina D,
po{to do sada nije ispitivana prevalencija deficijencije vitami -
na D u Srbiji. Ispitivane su karakteristike dve imunohemijske
me tode za odre|ivanje 25(OH)D, proizvo|a~a Roche (anal-
izator Cobas® e601) i Abbott (na analizatoru Architect). Me -
to de su pore|ene sa rezultatima HPLC analize kori{}enjem
25-(OH)-Vitamin D3/D2 r eagenasa firme Chromsystems
(Waters izokratski sistem). Da bi se pr ocenio status vitamina
D u op{toj populaciji, pretra`ena je baza podataka laborato -
rijskog informacionog sistema i analizirani su r ezultati 533
pacijenata kojima je odre|en 25(OH)D zajedno sa intaktnim
paratiroidnim hormonom (iPTH). Pripremljena su ~etiri se -
rumska pool-a sa koncentracijama 25(OH)D ∼ 35 nmol/L,
∼50 nmol/L, ∼75 nmol/L i ∼125 nmol/L za procenu nepre-
ciznosti imunohemijskih odre|ivanja. Dobijeni koeficijenti va -
rijacije za Roche metodu su se kretali u opsegu 1,5–2,8% u
seriji i 4,0–6,7% izme|u serija. Za Abbott metodu su koefi-
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Introduction
For years, vitamin D was consider ed essential
only for bone health in children and adults. However,
with the discover y of presence of vitamin D r eceptor
in most tissues and cells thr oughout the body , it
became clear that vitamin D had an important r ole
not only in the pr evention of osteoporosis and osteo-
malacia, but also in the pr evention of many chr onic
ilnesses, like cancers, autoimmune, infectious and
cardiovascular diseases (1). These findings have cau -
sed the considerable incr ease in number of r equests
for vitamin D status estimation, which initiated the
development of automated assays capable to cope
with this rise in laborator y workload.
The best biomarker of vitamin D status is its
circulating form, 25-hydroxyvitamin D [25-(OH)D].
There are two major vitamin D metabolites in the cir-
culation, endogenosly synthesized 25-hydroxyvitamin
D3 (cholecalciferol, 25(OH)D3), and 25-hydroxyvita-
min D2 (ergocalciferol, 25(OH)D2) derived from the
plants. Therefore, assays used to determine vitamin D
status and nutritional deficency should measur e both
cijenti varijacije iznosili 0,7–4,4% u seriji i 3,8–7,2% izme|u
serija. Neta~nost je ispitivana pomo}u komer cijalnih kontrol-
nih uzoraka. Dobijena odstupanja od deklarisane vrednosti su
iznosila 2,1% za Roche i 1,3–1,5% za Abbott, i nisu bila sta-
tisti~ki zna~ajna (P>0,05). P ore|enjem Roche i HPLC -UV
metoda pomo}u Passing-Bablok regresione analize dobijena
je slede}a regresiona jedna~ina y=0,937x+9,518 (r=0,739;
n=97), dok regresiona jedna~ina dobijena por e|enjem Ab -
bott i HPLC-UV metoda glasi y=0,745x+10,343 (r=0,793;
n=97). Srednja vrednost razlika na Bland-Altman dijagramu
razlika i standardna devijacija su iznosile –4,5 nmol/L i 21,75
nmo/L, redom, za Roche metodu i 6,4 nmol/L i 18,8 nmol/L,
re dom, za Abbott metodu. Statisti~ka analiza (Chi-kvadrat
test) distribucije frekvencija me|u razli~itim kategorijama
statusa vitamina D (<25 nmol/L te{ka deficijencija, 25–50
nmol/L deficijencija, 50–75 nmol/L insuficijencija i >75
nmol/L preporu~ena koncentracija) je pokazala da je distri -
bucija frek ven cija dobijena Abbott metodom zna~ajno raz li -
~ita od distribucije HPLC r ezultata, za razliku od ras po dele
frekvencija dobijene Roche metodom koja se nije zna~ajno
razlikovala. Tako|e, statisti~ka analiza slaganja izme|u ispiti-
vane tri me tode u svakoj od kategorija statusa vitamina D je
pokazala da su r ezultati i Roche i Abbott metoda zna~ajno
ve}i od HPLC -UV u kategorijama deficijencije vitamina D
(P=0,005 za Roche; P=0,0407 za Abbott), i u kategoriji sa
preporu~enom koncentracijom vitamina D Abbott metoda je
zna~ajno potcenjivala koncentraciju 25(OH)D u po re |e -
nju sa HPLC rezultatima (P<0,0001). Medijana za 25(OH)D
u ispitivanoj po pulaciji bila je 41,8 nmol/L, i 76,6 za iPTH .
ANOVA analiza je pokazala zna~ajan pad (P<0,05) koncen-
tracija iPTH i jonizovanog kalcijuma izme|u kategorija kon-
centracija 25(OH)D. Multiplom linearnom regresionom ana -
lizom utvr|ena je ne zavisna korelacija izme|u koncentracija
iPTH i 25(OH)D (b =–0,290; P=0,0008). Tako|e, ANOVA
za jedan kriterijum klasifikacije sa Student-Newman-K euls
testom je pokazala da su koncentracije 25(OH)D odre|ene u
leto i jesen zna~ajno vi{e (P<0,001) u por e|enju sa onima
odre|enim u zimu ili pr ole}e. Uprkos prihvatljivoj nepr eciz -
nosti i neta~nosti obe ispitivane imunohemijske metode, do -
bijeni rezultati nisu u zadovoljavaju}oj korelaciji sa HPLC-UV
metodom (r<0,9), koja je kori{}ena kao r eferentna u ovom
slu~aju. Uprkos ovoj ~injenici, metode su pokazale zadovo -
ljavaju}u sposobnost klasifikacije pacijenata u kategorije sta-
tusa vitamina D, {to je va`no za dijagnozu deficijencije vitami -
na D i pra}enje terapije. Oko dve tr e}ine (68,5%) ispitivane
populacije je imalo deficijenciju vitamina D (25(OH)D<50
nmol/L) i samo 8% je imalo pr eporu~enu koncentraciju
25(OH)D (>75 nmol/L).
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within- run and 3.8–7.2% for between-r un imprecision.
Inaccuracy was analyzed with commer cial control sera.
Obtained deviations from target value were 2.1% for Roche
assay and 1.3–1.5% for Abbott method, and were not statis-
tically significant (P>0.05). Comparison of R oche and
HPLC-UV methods using Passing-Bablok regression analysis
gave the following equation for the r egression line
y=0.937x+9.518 (r=0.739; n=97) and the regression line
equation from the comparison of Abbott and H PLC-UV
methods was y=0.745x+10.343 (r=0.793; n=97). Mean
difference and SD for Bland- Altman plot were –4.5 nmol/L
and 21.75 nmo/L, r espectively for Roche method and 6.4
nmol/L and 18.8 nmol/L, r espectively for Abbott. Statistical
analysis (Chi-square test) of frequency distribution among dif-
ferent vitamin D status categories (<25 nmol/L sever e defi-
ciency, 25–50 nmol/L deficiency, 50–75 nmol/L insufficien-
cy and >75 nmol/L sufficiency) showed that the fr equency
distribution obtained with Abbott method was significantly
different from the distribution of the HPLC results, in contrast
to Roche results frequency distribution which did not differ
significantly. Also, statistical analysis of the agr eement
between the three methods for each vitamin D status catego-
ry showed that r esults of both R oche and Abbott methods
were significantly higher than HPLC in the two deficiency cat-
egories (P=0.005 for Roche, P=0.0407 for Abbott), and in
the sufficiency category Abbott method significantly underes-
timated concentration of 25(OH)D compar ed to HPLC
results (P<0.0001). Median population values of 25(OH)D
and iPTH wer e 41.8 nmol/L and 76.6 ng/L, r espectively.
ANOVA analyses showed significant (P<0.05) d ecrease in
iPTH and Ca2+ concentrations across the 25(OH)D concentra-
tion categories. Stepwise multiple linear r egression analysis
indicated independent cor relation of iPTH with 25(OH)D
concentration (b=–0.290, P=0.0008). Also, one-way
ANOVA with Student-Newman-Keuls test demonstrated that
25(OH)D concentrations measured in summer and autumn
were significantly (P<0.001) higher compar ed to those
determined in winter and spring. Despite acceptable impreci-
sion and inaccuracy of both examined methods, r esults
obtained with them did not cor relate well with HPLC -UV
(r<0.9), which was used as a r eference. However, methods
showed satisfactory ability to classif y patients into vitamin D
status categories, which is important for diagnosis of vitamin
D deficiency and therapy follow-up. About two thirds (68.5%)
of the examined po pulation had vitamin D deficiency
(25(OH)D<50 nmol/L) and only 8% had sufficient 25(OH)D
concentration (>75 nmol/L).
Keywords: 25-hydroxyvitamin D, immunoassay , HPLC,
vitamin D status
forms, 25(OH)D2 and 25(OH)D3. In circulation, 95%
of circulating 25(OH)D represents 25(OH)D3, while
25(OH)D2 is usually a minor fraction, unless vitamin
D2 supplements are used by the patient. Measur e -
ment of 1,25-dihydroxyvitamin D [1,25(OH)2D], me -
ta bolicaly active for m of vitamin D, should not be
used to deter mine vitamin D status, since patients
with vitamin D deficiency and secondar y hyperpara -
thyroidism most of the time have nor mal or even
increased concentrations of 1,25(OH)2D (2).
Determination of 25(OH)D represents a unique
challenge, considering its lipophilic nature and strong
binding to vitamin D -binding protein (DBP). Tradi tio -
nally, assays for 25(OH)D contain pretreatment steps,
like deproteinization, extraction and purification, fol-
lowed by quantification. Depr oteinization or extrac-
tion frees metabolite fr om DBP and may partially
pu rify it. Purification steps, most of ten column chro -
ma tography, separate the various forms of vitamin D,
lipid and inter fering substances (3). P retreatment is
part of the two non-immunological assays, high per-
formance liquid chr omatography (HPLC) linked to
ultra-violet (UV) detector and linked to mass detec-
tors. The later pr ocedure is commonly ter med LC-
MS/MS or tandem mass spectr ometry (4). The two
candidate reference methods for 25(OH)D deter mi-
nation are the LC -MS/MS method by Tai et al. (5),
recognized by the Joint Committee for T raceability in
Laboratory Medicine, and LC -MS/MS method publi -
shed by the Laborator y for Analytical Chemistr y at
Ghent University (6). Unfortunately , these methods
are rather time consuming and laborious so that
nowadays there is a tendency for the development of
automated 25(OH)D methods. Cur rent commercial
immunoassays are founded on two major principles –
competitive protein binding assays that use DBP as
the binder, and immunoassays that employ polyclo nal
or monoclonal antibodies directed against 25(OH)D.
However, manufacturers of 25(OH)D immunoassay
methods had to replace pretreatment extraction step
with blocking agent in or der to include these immu -
noassays on automated platforms, which led to grea -
ter imprecision when compared to chromatographic
methods. Also, these methods ar e often limited in
equipotent quantification of both for ms of 25(OH)D
– 25(OH)D3 and 25(OH)D2, compared with HPLC
and LC-MS/MS methods which quantitatively meas-
ure circulating concentrations of both forms (7, 8).
For the reasons mentioned above, and because
of the lack of har monization of all assays, it is not a
rare case that a physician obtain differ ent results of
25(OH)D measurement for an individual patient from
different laboratories that use assays based on differ-
ent measuring principles or fr om different manufac-
turers (9). Ther efore, the aim of this study was to
compare two automated immunoassays with HPLC -
UV method for the measur ement of 25(OH)D that
are commonly used and available in laboratories of
the Center for Medical Biochemistr y of the Clinical
Centre of Serbia. Since numer ous studies have r e -
vealed that the pr evalence of vitamin D deficiency
and insuficiency is >50% in the general population,
and considering uncovered associations with incr ea -
sed risks for hypertension, type II diabetes, color ectal
and breast cancers, myocar dial infarction, strokes,
and peripheral vascular disease (1, 10), the aim was
also to estimate vitamin D status among Serbian pop-
ulation, since up to date the pr evalence of vitamin D
deficiency in Serbia was not examined.
Material and Methods
Comparison Studies
For method comparison we used 100 ser um
samples from routine 25(OH)D assay r equests pro -
cessed in the laborator y of Department for P oliclinic
Laboratory Diagnostics in the Center for Medical
Biochemistry of Clinical Centre of Serbia in Belgrade.
Remained amounts of samples, af ter the completion
of analysis r equested by attending physicians, wer e
aliquoted, stored at –70 °C and analyzed in batch with
all three methods. For three samples, the collected
volume was <500 µL, which was not enough for
analysis with the HPLC-UV method, why we used the
results of 25(OH)D deter mination in 97 samples for
statistical analysis. We compared results of 25(OH)D
determination obtained with electr ochemilumines-
cent immunoassay, Elecsys® Vitamin D total (R oche
Diagnostics GmbH, Mannheim, Germany) performed
on Cobas® e601 analyzer, and of chemiluminescent
microparticle immunoassay, ARCHITECT 25-(OH)
vitamin D (Abbott Diagnostics, Wiesbaden, Germany)
performed on Ar chitect® ci8200 analyzer, with the
results of HPLC analysis of 25-(OH)- Vitamin D3/D2
(Chrom systems Instruments & Chemicals GmbH ,
Munich, Germany) using Waters isocratic HPLC -UV
system. The Roche method uses competitive pr otein
binding principle and the Abbott method employs
sheep polyclonal antibodies directed against 25(OH)D.
HPLC-UV method was used as the reference for com-
parison because, by means of efficient pr otein preci -
pitation and selective solid phase extraction, inter fe -
ring components ar e removed and the analytes ar e
concentrated, which increases the sensitivity and spe -
cificity of this method of determination. 
For imprecision assessment of chemilumines-
cent immunoassays, four serum pools were prepared.
Samples were mixed to obtain the following 25(OH)D
concentrations: ∼35 nmoL/L, ∼50 nmol/L, ∼75 nmol/L
and ∼125 nmol/L. Each pool was aliquoted and
stored at –70 °C until use. For within-run imprecision
25(OH)D was determined in each serum pool with 10
replicates per run. Between-run imprecision was eva -
luated by analyzing every pool on 10 successive days
on the basis of a single calibration. Inaccuracy was
analyzed with commercial control sera for cor respon -
ding methods (PreciControl Bone, Roche Dia g nostics
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GmbH, Mannheim, Ger many, and ARCHI TECT 25-
(OH) Vitamin D Contr ols, Abbott Diag no stics, Wies -
baden, Germany). 25(OH)D concentration in each
control serum was measured 20 times to deter mine
bias from expected values.
The concentrations of 25(OH)D in 97 ser um
samples measured with the two chemiluminescent
immunoassays and the HPLC-UV method were statis-
tically analyzed by P assing-Bablok regression and
Bland-Altman plots (11, 12). 
In order to evaluate concor dance between the
methods more accurately, their agreement in the abil-
ity to diagnose vitamin D deficiency was examined.
25(OH)D concentrations measured in 97 serum sam-
ples were classified into categories accor ding to the
vitamin D status. The categories were defined on the
basis of established cut-off values for severe deficien-
cy (<25 nmol/L), deficiency (25–50 nmol/L), insuffi-
ciency (50–75 nmol/L) and sufficiency (>75 nmol/L)
(1). The frequency distribution of results of 25(OH)D
determinations with HPLC -UV method accor ding to
these categories was compared with frequency distri-
butions of 25(OH)D r esults obtained with both che -
miluminescent immunoassays. W e used Chi-squar e
test on frequency table to determine whether the fre-
quency distributions of immunoassay results were sig-
nificantly different from the distribution of HPLC -UV
values. Statistical analysis of mean differ ence of
25(OH)D concentrations obtained with HPLC -UV
and immunoassays for each vitamin D status catego-
ry was also per formed. Category classification was
based on values obtained by HPLC -UV method. Stu -
dent t-test was used to determine whether there were
differences between means in cor responding cate-
gories obtained with HPLC-UV method and examined
immunoassays.
Vitamin D status estimation 
To estimate vitamin D status in Serbian popula-
tion, we sear ched the database of the laborator y
information system (LabOnLine V er. 2 R el. 2.03;
Omni lab, Milan, Italy) in the Department of Polyclinic
Laboratory Diagnostics of the Center for Medical
Biochemistry in Clinical Centr e of Serbia. F rom over
2000 determinations of 25(OH)D 3, using Elecsys ®
Vitamin D3 (25-OH) assay, in period fr om 4 No -
vember 2008. to 26 May 2010., 533 patients had
also the values for intact parathyroid hormone (iPTH),
total and ionized calcium and inor ganic phosphorus,
and this gr oup of r esults was included in statistical
analysis of vitamin D status in Serbian population.
Normally distributed continuous variables ar e
presented as the mean and standar d deviation. To
determine whether the distribution was Gaussian
Kolomogorov-Smirnoff test was applied. Continuous
variables with non-Gaussian distribution are present-
ed as geometric mean and 95% confidence inter val
(CI) for mean, and in consecutive statistical analysis
have been log transfor med. The ser um 25(OH)D3
concentrations were categorized into four vitamin D
status groups. Comparison of mean values of contin-
uous variables between categories was per formed by
one-way ANOVA. Chi-square test for contingency
tables was used for the analysis of categorical vari-
ables. Multiple linear regression analysis was conduct-
ed to deter mine independent contribution of exam-
ined variables to the change in concentration of
25(OH)D3. 
We analyzed the seasonal variation of 25(OH)D
in the examined population. Time period for individ-
ual season was defined accor ding to the calendar as
spring from 21 March to 21 June, summer fr om 22
June to 22 September, autumn from 23 September to
21 December, and winter fr om 22 December to 20
March. Average concentrations in each season wer e
compared using one-way ANOVA. Also, we examined
the frequency distribution of each vitamin D status
category depending on the season using Chi-squar e
test.
Statistical significance was assumed at P<0.05.
We performed all statistical calculations using Med -
Calc® Ver. 12.1.3 (MedCalc sof tware, Mariakerke,
Belgium), CB Stat V er. 4.3 (Kristian Linnet, Risskov ,
Denmark) and SPSS for W indows 11.5 (Chicago,
Illinois, USA) computer softwares.
Results
Comparison Studies
Results of the imprecision assessment of the two
examined chemiluminescent immunoassys ar e pre-
sented in Table I. Analysis of four ser um pools with
wide range of 25(OH)D concentrations obtained
within-run imprecision (CV) in the range 0.7–4.4% for
Abbott and 1.5–2.8% for R oche immunoassay, and
between-run CVs wer e 3.8–7.2% and 4.0–6.7% for
Abbott and Roche, respectively. 
Results of Student t-test showed that there were
no statistically significant differ ences between means
of results of repeated measurements of 25(OH)D and
expected values of analyzed contr ol sera, with bias
around 2.1% for R oche and between 1.3 and 1.5%
for Abbott assay (Table II). 
The correlation of results of 25(OH)D determina-
tion obtained using chemiluminescent immuno assays
and HPLC-UV results was examined with P as sing-
Bablok regression analysis. Spear man’s cor re la tion
coefficients for Abbott and Roche methods were 0.793
and 0.739, respectively. Regression equations showed
proportional bias significantly differ ent from 0 for
Abbott method, which was 10.343 nmol/L (95%
CI=3.531–15.485 nmol/L, P<0.05), but not for the
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Roche method, wher e it was 9.518 nmol/L (95%
CI=–1.748–16.727, P>0.05). The constant bias was
0.745 for the Abbott method, which was also signifi-
cantly different from 1 (95% CI=0.641–0.857,
P<0.05), and not for the Roche method with the value
of 0.939 (95% CI=0.791–1.129, P>0.05) ( Figures
1A and 1B). 
The agreement between HPLC-UV and immu -
no assays was also examined using Bland- Altman dif-
ference plots. The absolute differ ence plot showed
the mean differ ence between HPLC and Abbott
method of 6.4 nmol/L (95% CI=–31.4 –44.1 nmol/L)
and between HPLC and Roche method of–4.5 nmol/L
(95% CI=–48.0–39.0 nmol/L) (Figures 1C and 1D).
The correlation coefficients between the numerical
value of the differ ence between HPLC and Abbott
and the mean value of these two deter minations was
r=0.342, which was significantly differ ent from 0
(P<0.001), and for HPLC and R oche was r=0.203
(0.02<P<0.05), meaning that the scatter of dif -
ferences tends to incr ease proportionally with the
measurement level. This was confirmed on the rela-
tive difference plot, wher e the mean r elative diffe -
rence between HPLC and Abbott was 6.9% (95%
CI=–66.8–80.6%), with r=–0.23 significantly dif -
ferent from 0 (0.01<P<0.05), and –10.7% (95%
CI=–93.3–72.0%) with r=–0.424 (P<0.001) for
HPLC and Roche, showing that the scatter of r elative
differences was not constant for either methods
(Figures 1E and 1F).
The frequency distribution in vitamin D status
categories obtained according to results of 25(OH)D
determinations with HPLC-UV method was used as a
reference in comparison with fr equency distributions
based on results of chemiluminescent immunoassays
(data not shown). R esults of Chi-square test showed
statistically significant differ ence between the distri -
butions of concentrations obtained with HPLC and
Abbott methods (P=0.0293), but the differ ence bet -
ween HPLC and R oche distributions was not signifi-
cantly different (P=0.1858).
Statistical analysis of difference between means
of 25(OH)D concentrations obtained with HPLC -UV
and immunoassays for each vitamin D status catego-
ry is presented in Table III. The results showed statis-
tically significant difference for mean values obtained
with the Abbott method from HPLC results in the ca -
tegory of severe deficiency (<25 nmol/L) and suffi-
ciency (>75 nmol/L), while the difference had borde-
line significance (P=0.0521) in the group of persons
with insufficiency (50–75 nmol/L). The mean con-
centrations of 25(OH)D determined using the Roche
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Table I Within-run and between-run imprecision assessment for 25(OH)D determination by Roche and Abbott immunoassays.
pool
Within-run Between-run
Roche Abbott Roche Abbot
⎯x
(nmol/L)
SD
(nmol/L)
CV
(%)
⎯x
(nmol/L)
SD
(nmol/L)
CV
(%)
⎯x
(nmol/L)
SD
(nmol/L)
CV
(%)
⎯x
(nmol/L)
SD
(nmol/L)
CV
(%)
1 49.0 1.35 2.8 49.2 1.18 2.4 49.5 2.00 4.0 48.8 1.85 3.8
2 78.8 2.12 2.7 79.8 1.32 1.7 81.0 4.02 5.0 79.2 4.25 5.4
3 126.0 1.88 1.5 125.8 0.88 0.7 127.5 5.38 4.2 125.8 7.30 5.8
4 37.2 1.05 2.8 35.5 1.55 4.4 36.5 2.42 6.7 34.5 2.48 7.2
Table II Inaccuracy assessment for 25(OH)D determination by Roche and Abbott immunoassay (N=20; t0.05=2.101).
Control
Expected value
(nmol/L)
⎯x
(nmol/L)
SD
(nmol/L)
t0.05 P*
Bias
(%)
Roche
PC Bone 1 35.2 36.0 2.28 1.936 0.0612 2.1
PC Bone 2 71.8 73.2 6.05 1.603 0.1169 2.1
Abbott
Control L 50.0 49.2 1.18 1.751 0.1138 1.3
Control M 100.0 101.5 3.98 1.234 0.2484 1.5
Control H 187.5 184.8 5.70 1.472 0.1752 1.5
*P>0.05 – no statistically significant difference
method were significantly different from those obtai -
ned with HPLC in both deficiency categories (values
obtained with the R oche method wer e higher than
those obtained with HPLC), while they wer e not sig-
nificantly different from the HPLC r esults in insuffi-
ciency and sufficiency categories.
Vitamin D status estamination
Median 25(OH)D3 concentration in the exam-
ined population was 41.8 nmol/L. Among selected
results from the laborator y information system data
base, 134 individuals had 25(OH)D3<25 nmol/L (12
Figure 1 Comparison of Abbott and R oche immunoassays against HPLC -UV by Passing-Bablok regression analysis (panels A
and B, respectively) and Bland-Altman plots (panels C–F). On Passing-Bablok plots the full line represents the regression line and
the dotted line r epresents the line of unity y=x. P anels C and D r epresent absolute difference plots, and panels E and F show
relative difference plots for Abbott and Roche immunoassays against HPLC, respectively. On Bland-Altman plots, the mean dif-
ference in the absolute differ ence plot and the mean r elative difference in the r elative difference plot are displayed as dotte d
lines, and the 95%-confidence limits for individual absolute and r elative differences are displayed as dashed lines.
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males, 122 females), in 231 individuals (42 males,
189 females) 25(OH)D3 was 25–50 nmol/L, 124 per-
sons (14 males, 110 females) had 25(OH)D3 bet ween
50 and 75 nmol/L and in the category of 25(OH)D3>
75 nmol/L 44 persons wer e classified (4 females, 40
males). Characteristics according to the four vitamin D
status groups are summarized in Table IV.
ANOVA analysis indicated significant (P<0.05)
changes in ionized calcium concentration (P=0.016)
and significant decr ease in iPTH concentraction
(P=0.027) with the incr ease of 25(OH) concen -
tration, while the changes in concentrations of total
calcium showed bor derline significance (P=0.058).
Chi-square test r evealed significant differ ence in the
per cent of gender distribution among vitamin D status
categories (P=0.047). Consequently, a stepwise mul-
tiple linear regression model showed that the concen-
tration of 25(OH)D3 correlated significantly only with
iPTH (b=–0.290, P=0.0008). It explained 6.5% of
the variance in the values of 25(OH)D 3 (P=0.001). 
Average concentrations of 25(OH)D 3 in dif -
ferent seasons ar e compared with one-way ANO VA
and the results are presented in Table V. The results
showed statistically significant differ ence in the aver-
age 25(OH)D3 concentration depending on the sea-
son. Concentrations were significantly higher in sum-
mer and autumn when compar ed with those
measured in winter or spring.
Table III Statistical analysis of method differences by vitamin D status categories.
a Vitamin D status assignment of samples was based on their HPLC r esults of 25(OH)D.
b A t-test was performed to determine whether means of 25(OH)D values obtained from Abbott and Roche methods were statis-
tically significantly different from those obtained by the HPLC-UV method.
25(OH)D
(nmol/L)
⎯x, nmol/L HPLC-Abbott HPLC-Roche
HPLC Abbott Roche
Mean 
differencea
(nmol/L)
SD of 
difference,
(nmo/L)
Pb
Mean 
differencea
(nmol/L)
SD of 
difference,
(nmol/L)
Pb
<25 18.38 24.72 32.28 –6.34 11.575 0.0407 –13.90 11.775 0.0005
25–50 36.95 39.80 47.45 –2.85 10.650 0.1497 –10.50 17.275 0.0115
50–75 61.90 56.30 66.58 5.60 13.575 0.0521 –4.68 20.675 0.2688
>75 95.88 74.72 90.48 21.15 22.375 <0.0001 5.40 27.325 0.2914
Table IV Characteristics of the examined population according to four groups of 25(OH)D3 levels.
a One-way ANOVA across the four 25(OH)D level groups for continuous variables and chi-square test for categorical variables.
b Statistical tests on log10-transformed values.
c Geometric mean and 95% confidence inter val (CI) for mean.
d Arithmetic mean ± SD.
Ca, calcium; Ca2+, ionized calcium; P, inorganic phosphorus; iPTH, intact parathyroid hormone; 25(OH)D3, 25-hydroxyvitamin D3.
25(OH)D3, nmol/L
Pa<25
n=134
(25.1%)
25–50
n=231
(43.3%)
50–75
n=124
(23.3%)
>75
n=44
(8.3%)
Ageb, c
(years)
56.9
(54.3–59.6)
54.8
(52.7–56.9)
57.3
(54.8–59.8)
52.4
(48.1–57.4) 0.181
Gender
(male/female) 12/122 42/189 14/110 4/40 0.047
Cad
(mmol/L)
2.37±0.150 2.42±0.167 2.35±0.164 2.38±0.119 0.058
Ca2+ b, c
(mmol/)L
1.28
(1.24–0.31)
1.28
(1.26–1.30)
1.23
(1.21–1.26)
1.29
(1.26–1.33) 0.016
Pd (mmol/L) 1.16±0.175 1.12±0.211 1.16±0.164 1.16±0.119 0.504
iPTHb, c
(ng/L)
74.4
(67.0–82.7)
64.1
(59.9–68.8)
63.2
(57.4–69.7)
59.1
(50.6–69.0) 0.027
25(OH)D3b, c
(nmo/L)
14.2
(13.0–15.5)
37.0
(36.0–38.0)
59.5
(58.2–60.5)
89.2
(84.5–94.2) <0.0001
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Also, we examined the frequency distribution of
individual vitamin D status categories in different sea-
sons. Chi-square test showed that the differ ences in
the distribution are statistically significant (P<0.0001),
where the percentage of persons with 25(OH)D3 con-
centration <25 nmol/L varied significantly between
seasons, and the highest was in winter (38.1%) and
spring (40.3%). Also, the per centage of persons with
25(OH)D3 concentration in the range 25–50 nmol/L
changed significantly (P<0.0001) and the highest
was in spring, 46.9%. The percentage of persons with
25(OH)D3 concentration between 50 and 75 nmol/L
was relatively constant and ther e was no significant
difference between seasons (P=0.7010), while, as
expected, the percentage of persons with 25(OH)D 3
values >75 nmol/L changed significantly (P=0.036)
and the highest was in summer (28.6%). Cr oss-clas-
sification of vitamin D status fr equency distribution
among seasons is represented in Table VI.
Discussion
Because of the gr eat differences between the
determination principles of various 25(OH)D meth-
ods, the variation of results among laboratories using
different methods exists. In Serbia, most of the labo-
ratories use several immunoassays for 25(OH)D de -
termination, depending on the automated platfor m
available. In this study, we compared the two immu -
no assays used in the laborator y of Department for
Polyclinic Laboratory Diagnostics in the Center for
Medical Biochemistry of Clinical Centr e of Serbia in
Belgrade with the commercial HPLC method with UV
detection. Immunoassays used differ ent principles –
competitive protein binding (R oche) and polyclonal
sheep antibody employment (Abbott). For both meth-
ods is stated that they determine both 25(OH)D2 and
25(OH)D3, though the determination of 25(OH)D2 is
of little importance in Serbia, since the registered sup-
plements are only vitamin D 3 preparations. We used
the HPLC-UV method as a reference because it uses
completely different principle and r equests sample
pretreatment which removes interferences.
Imprecision assessment of the two immunoas-
says was conducted using four ser um pools which
encompassed a wide range of 25(OH)D concentra-
tions (Table I) and inaccuracy was examined using
corresponding commercial control sera for each
method (Table II). The obtained r esults were within
the defined limits according to specifications for true-
ness and precision for 25(OH)D analysis for r outine
testing, where imprecision and bias should be ≤10%
and ≤5%, respectively (13, 14). 
However, the comparison of the two immunoas-
says with HPLC -UV method as a r eference using
Passing-Bablok regression analysis gave cor relation
coeficients <0.9, which showed that the agr eement
and correlation between methods was not accept-
able. Besides, obtained slope and inter cept together
with the Bland-Altman analysis showed the statistical-
ly significant difference between the pair ed determi-
nations for both HPLC–R oche and HPLC–Abbott.
Season
P
spring summer autumn winter
25(OH)D1a
(nmo/L)
31.22, 3
(28.68–34.05)
58.41,3,4
(52.68–64.75)
37.81,2,4
(34.00–42.12)
30.22,3
(37.02–33.72)
<0.001
season
total P*
spring summer autumn winter
25(OH)D
(nmo/L)
<25 54 5 24 51 134 <0.0001
25–50 82 12 62 75 231 <0.0001
50–75 32 28 28 36 124 0.7010
>75 7 18 13 6 44 0.036
total 175 63 127 168 533 <0.0001
Table V One-way ANOVA of differences in 25(OH)D concentration between seasons.
Table VI Frequency distribution in vitamin D status categories in differ ent seasons.
aGeometric mean and 95% confidence inter val (CI) for mean
1significantly different from the first group (spring) – Student-Newman-Keuls test
2significantly different from the second group (summer) – Student-Newman-Keuls test
3significantly different from the third group (autumn) – Student-Newman-Keuls test
4significantly different from the fourth group (winter) – Student-Newman-Keuls test
*Chi-square test on tabulated data.
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These differences were not constant, but rather in -
creased with the 25(OH)D concentration. The lack of
correlation between immunoassays and HPLC reflect-
ed on their agr eement in the diagnosis of vitamin D
deficiency. The results of Chi-square test showed sig-
nificant difference between the frequency distribution
across vitamin D status categories only between
Abbott and HPLC but not for Roche. However, exam-
ination of differences in means of 25(OH)D concen-
trations obtained with HPLC -UV and immunoassays
for each vitamin D status category (Table III) revealed
significant differences for both immunoassays, with
the Roche method giving higher values in the sever e
deficiency and deficiency categor y, and the higher
values were obtained in the severe deficiency catego-
ry and lower r esults in the sufficiency categor y with
the Abbott method.
First of all, the lack of satisfactory analytical cor-
relation between the examined immunoassays and
HPLC-UV could be explained with the differ ent cali-
brator traceability. For calibration of the HPLC met -
hod National Institute for Standar ds and Technology
standard reference material (NIST SRM 2972) was
used as the primar y reference material, which is also
used as the calibrator for the r eference LC-MS/MS
method. Roche method can also be traceable to the
same primary reference material thr ough standardi-
zation against LC-MS/MS calibrated with NIST SRM
2972. This might be the r eason for somewhat better
agreement of the R oche method with HPLC, com-
pared with the Abbott method, which was standar d-
ized against inter nal reference material. Also, poor
method comparability may be r elated to the specifi -
city of different methods and the possibility to cr oss-
react with other metabolites of 25(OH)D. Most
immu noassays, for example, show significant cr oss-
reactivity with dihydroxy and other vitamin D metabo-
lites – 24,25(OH) 2D3, 25,26(OH)2D3, 25(OH)D3-
26,23-lactone. These metabolites, especially 24,25-
dihydroxyvitamin D metabolites, cir culate at up to
10–15% of the 25(OH)D concentration and their pre -
sence could incr ease the 25(OH)D concentration
mea sured by immunoassays (4). This may explain
higher values obtained with immunoassays when
determining values of 25(OH)D below 50 nmol/L,
which is the bor der between deficiency and insuffi-
ciency. Also, spuriously high results may be caused by
matrix effects, which occur between the matrix in cal-
ibrators and patient samples in the pr esence of other
lipids in ser um or plasma sample, that change the
ability of the binding agent to associate with
25(OH)D in the sample and the standar d in equal
fashion (4). Hopefully, these issues with the examined
and other immunoassays will be minimized when the
results of the ongoing Vitamin D Standar dization
Program (VDSP) ar e published, which should intr o-
duce SRM 972a, the human serum panel for calibra-
tion of immunoassays (15, 16).
Although the correlation between HPLC-UV and
immunoassays was not satisfactor y, mean values of
immunoassay results in each vitamin D status catego-
ry defined accor ding to HPLC did not exceed the
cate gory limit (Table III). This implies that the exam-
ined immunoassays have acceptable ability to classify
patients into appropriate vitamin D status categories,
which is important for diagnosis of vitamin D deficien-
cy and monitoring supplementation therapy . Both
methods overestimate the values in the sever e defi-
ciency category, with R oche means exceeding the
category limit of 25 nmol/L, but the mean values
remain within the deficiency categor y (25–50
nmol/L) where therapy is indicated. The potential
problem might be the under estimation of r esults
obtained with Abbott assay in the sufficiency catego-
ry, where mean value r emain below the sufficiency
limit of 75 nmol/L. This might draw the wr ong con-
clusion that the patient is not r esponding to supple-
mentation treatment.
The limitation of this study was that HPLC-UV is
not a reference method for 25(OH)D deter mination.
For definitive assessment of analytical characteristics
of two examined immunoassays, they should be com-
pared with the reference LC-MS/MS method.
Numerous studies have assessed the prevalence
of vitamin D deficiency in general population
(17–20). Up to date the prevalence of vitamin D defi-
ciency in Serbia was not examined. If we use the 50
nmol/L values as the cut off between the deficiency
and relative insufficiency, 68.5% of examined popula-
tion lack vitamin D, while 25.1% is alr eady under
severe deficiency, with 25(OH)D concentration <25
nmol/L (Table IV). Only about 8% of population have
sufficient 25(OH)D concentration. The situation is
similar in USA, where the prevalence of low 25(OH)D
concentrations (<50 nmol/L) is ar ound 36% in
healthy young persons 18–29 years old, 42% in
African-American women age between 15 and 49,
41% in outpatients 43–83 years of age and up to
57% of hospital patients. In Europe, the prevalence is
even higher, with 28–100% in healthy persons and
70–100% in hospital patients (21).
The low vitamin D levels in examined population
was accompanied by incr ease in iPTH concentration
(Table IV), which was showed to be statistically signif-
icant with one-way ANO VA and confir med its in -
dependent influence in the change of 25(OH)D con-
centration using multiple linear r egression analysis.
These results are in accor dance with other studies
which found negative cor relation between 25(OH)D
and iPTH levels (17, 19).
Concentration of 25(OH)D significantly varied
with the change of seasons, reaching maximum con-
centrations in summer and minimum in winter and
spring (Table V). Percentage of persons with 25(OH)D
concentration <25 nmol/L was the highest in winter
(38.1%) and in spring (40.3%), while the per centage
of people with 25(OH)D concentration >75 nmol/L
was the highest in summer, when it was 28.6% (Table
VI). There are several potential explanations for high
prevalence of vitamin D deficiency in Serbian popu -
lation. It is consider ed that 90% of necessar y amount
of vitamin D is synthesized in the skin af ter the expo-
sure to sunlight. Anything that disturbs the penetra-
tion of UV radiation into the skin will r educe vitamin
D3 production in skin, including clothes and sun-
screens. Also, solar UV radiation exposur e is influ-
enced by altitude, season, pollution and clouds (22).
On latitudes above 37° N and below 37° S, the inten-
sity of solar radiation is not enough to induce vitamin
D3 synthesis during winter months (1, 21). R easons
that promote vitamin D deficiency in older persons
include decreased food intake, decr eased sun expo-
sure, but also the decreased ability of the skin to syn-
thesize vitamin D3. In the skin of 70 year old person,
skin’s ability to synthesize vitamin D3 is four times less
compared with the 20-year old (23, 24). Dietar y
sources of vitamin D ar e limited and intake of ade-
quate amounts of ten represents a problem for most
people whose diet does not include rar e natural
sources. Also, patients with malabsorption ar e under
particular risk of vitamin D deficiency. 
Serbia is located at the 44° N, which is above
the mentioned 37° N and where the sunlight intensi-
ty is not enough to induce vitamin D3 synthesis in the
skin during the winter. For this reason, concentrations
achieved during summer should be high enough to
provide the amounts of vitamin D thr oughout the
year. Since even in the period of the highest synthesis
25(OH)D concentration does not reach the cutoff for
sufficiency of 75 nmol/L, in the examined population
we have median iPTH concentration of 65 ng/L,
which is at the very upper limit of the reference inter-
val (15–65 ng/L), and represents an increased risk for
secondary hyperparathyroidism. This is contributed by
the diet, traditionally poor in fatty sea fish and fish oil,
natural sources of vitamin D, while there is no nation-
al program of food fortification.
This study of vitamin D deficiency pr evalence
have certain limitations since the examination was not
controlled and other infor mation about participants
and their medical history weren’t available, except for
gender and age. Also, other parameters which would
be significant for vitamin D status assessment, like
creatinin, as an indicator of kidney function, and lipid
status, weren’t known.
In conclusion, even though the lack of standard-
ization of immunoassays and chromatographic meth-
ods for 25(OH)D status deter mination exists, why
most probably we have obtained poor method com-
parison results, examined immunoassays showed sat-
isfactory results in classifying patients into appropriate
vitamin D status categories compared with HPLC-UV
method. Although the results for vitamin D deficiency
prevalence showed significant number of vitamin D
deficient individuals, these findings must be consid-
ered as pr eliminary, because the analyzed r esults
belonged to persons whose medical histor y was not
available and the sample size was too small to draw
conclusions regarding the general population. Even
with these limitations, high pr evalence of vitamin D
deficiency in the examined population should alar m
health services to initiate vitamin D food fortification
program, because this is known to be the most suc-
cessful way of pr eventing health complications
caused with vitamin D deficiency.
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